[The first oral thrombin inhibitor. Competition to heparins and marcumar?].
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001384:Azetidines / Q000008:administration & dosage*; D001596:Benzylamines; D002986:Clinical Trials as Topic; D017984:Enoxaparin / Q000008:administration & dosage / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005998:Glycine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D006801:Humans; D010644:Phenprocoumon / Q000008:administration & dosage / Q000627:therapeutic use; D010919:Placebos; D011355:Prodrugs; D013917:Thrombin / Q000037:antagonists & inhibitors*; D013923:Thromboembolism / Q000517:prevention & control; D013927:Thrombosis / Q000517:prevention & control*; D013997:Time Factors
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; D017984:Enoxaparin; D005343:Fibrinolytic Agents; D010919:Placebos; D011355:Prodrugs; C109573:melagatran; C426686:ximelagatran; D013917:Thrombin; D010644:Phenprocoumon; D005998:Glycine
Der erste orale Thrombininhibitor. Konkurrenz für Heparine und Marcumar?